ROLE OF COMBINED 18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IN THE MANAGEMENT OF PATIENTS WITH DIFFERENTIATED THYROID CANCER
Owing to the setting up of new nuclear medicine centers, not only choiceless treatment, such as radioactive iodine therapy, but also an indispensable technique in examination, such as 18-fluorodeoxyglucose positron 3m speedglas 9002nc emission tomography/computed tomography (18FDG PET/CT), has become available to many patients with differentiated t